Real-time enrollment status for this scleroderma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:59 AM UTC
| NCT Number | NCT06655896 |
| Recruiting Status | Recruiting |
| Condition | Scleroderma |
| Phase | PHASE2 |
| Target Enrollment | 96 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 8, 2026 (1 week ago) |
As of July 19, 2026: Clinical trial NCT06655896 is currently recruiting participants. This phase2 study for scleroderma is actively seeking new participants at 14 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06655896 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06655896 was last updated 1 week ago (July 8, 2026). HelloStudys verifies this status automatically.